These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 29545449

  • 21. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 22. Prognosis and management of polymyalgia rheumatica.
    Jones JG, Hazleman BL.
    Ann Rheum Dis; 1981 Feb 01; 40(1):1-5. PubMed ID: 7469518
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
    González-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J.
    Ann Rheum Dis; 2001 Apr 01; 60(4):367-71. PubMed ID: 11247867
    [Abstract] [Full Text] [Related]

  • 30. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
    Gonzalez-Gay MA.
    Semin Arthritis Rheum; 2004 Apr 01; 33(5):289-93. PubMed ID: 15079759
    [Abstract] [Full Text] [Related]

  • 31. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
    Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Smeeth L, Hemingway H.
    Heart; 2016 Mar 01; 102(5):383-9. PubMed ID: 26786818
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
    Unizony S, McCulley TJ, Spiera R, Pei J, Sidiropoulos PN, Best JH, Birchwood C, Pavlov A, Stone JH.
    Arthritis Res Ther; 2021 Jan 06; 23(1):8. PubMed ID: 33407817
    [Abstract] [Full Text] [Related]

  • 34. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
    Nielsen AW, Frølund LL, Våben C, Bonde AR, Gormsen LC, de Thurah AL, Hauge EM, Keller KK.
    Semin Arthritis Rheum; 2022 Oct 06; 56():152069. PubMed ID: 35858507
    [Abstract] [Full Text] [Related]

  • 35. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Pipitone N, Versari A, Hunder GG.
    Nat Rev Rheumatol; 2012 Sep 06; 8(9):509-21. PubMed ID: 22825731
    [Abstract] [Full Text] [Related]

  • 36. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
    Liozon E, Parreau S, Filloux M, Dumonteil S, Gondran G, Bezanahary H, Ly KH, Fauchais AL.
    Autoimmun Rev; 2021 Feb 06; 20(2):102732. PubMed ID: 33326851
    [Abstract] [Full Text] [Related]

  • 37. Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States.
    Michailidou D, Zhang T, Stamatis P, Ng B.
    J Intern Med; 2022 May 06; 291(5):665-675. PubMed ID: 34982490
    [Abstract] [Full Text] [Related]

  • 38. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
    Baerlecken NT, Linnemann A, Gross WL, Moosig F, Vazquez-Rodriguez TR, Gonzalez-Gay MA, Martin J, Kötter I, Henes JC, Melchers I, Vaith P, Schmidt RE, Witte T.
    Ann Rheum Dis; 2012 Jun 06; 71(6):943-7. PubMed ID: 22228484
    [Abstract] [Full Text] [Related]

  • 39. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep 06; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 40. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
    Ungprasert P, Sanguankeo A, Upala S, Knight EL.
    Semin Arthritis Rheum; 2014 Dec 06; 44(3):366-70. PubMed ID: 25074657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.